Description
Aessoa Ultra with Lidocaine Hyaluronic Acid Dermal Filler for Volumisation and Facial Contour Enhancement
Aessoa Ultra with Lidocaine is a hyaluronic-acid–based dermal filler classified as a cross-linked HA soft-tissue implant for aesthetic correction. It is supplied in a sterile, prefilled syringe and incorporates lidocaine hydrochloride to support patient comfort during injection. The product is intended for professional aesthetic use where enhanced projection, volume, and contour definition are required.
The mechanism of action is based on the viscoelastic and hydrophilic properties of cross-linked hyaluronic acid, which integrates into the extracellular matrix and provides mechanical support by binding water molecules and resisting deformation under pressure. The “Ultra” designation is commonly associated with firmer gel characteristics compared with more superficial fillers, although exact rheological parameters are not disclosed by the manufacturer.
What Aessoa Ultra with Lidocaine Is Similar To
Aessoa Ultra with Lidocaine belongs to the category of firm, cross-linked hyaluronic acid dermal fillers designed for volumisation and contour support. Products in this category are formulated to provide greater resistance to deformation compared with softer HA gels, making them suitable for areas requiring projection or shape retention.
For clinical orientation, Aessoa Ultra may be compared with fillers such as Juvéderm® Ultra or Restylane® Defyne, which also use cross-linked HA technology to support volume and contouring in deeper tissue planes. While these products share a similar mechanism of action, they differ in HA concentration, cross-linking methods, gel elasticity, and manufacturer-defined indications .
Longevity and tissue integration vary between products and patients, and selection should always be based on clinical judgment and official IFU documentation.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
Treatment areas are not provided by manufacturer in publicly available IFU documentation.
Usage / Administration (IFU-only section)
The manufacturer’s official IFU for Aessoa Ultra with Lidocaine is not publicly accessible online. As such, the following parameters are not provided by manufacturer:
-
Injection depth: not provided by manufacturer
-
Volume per point / injection site: not provided by manufacturer
-
Needle gauge: not provided by manufacturer
-
Frequency / number of sessions: not provided by manufacturer
Ingredient List
-
Cross-linked hyaluronic acid: concentration not provided by manufacturer
-
Lidocaine hydrochloride: percentage not provided by manufacturer
-
Physiological buffer / excipients: not provided by manufacturer
Presentation & Longevity
-
Presentation: 1 × 1 ml sterile prefilled syringe
-
Shelf life: not provided by manufacturer
-
Treatment duration / longevity: not provided by manufacturer
Clinical persistence may vary depending on patient factors, injection site, and practitioner technique; however, no official longevity range is stated in manufacturer documentation.
FAQ
1: What type of dermal filler is Aessoa Ultra with Lidocaine?
Aessoa Ultra with Lidocaine is a cross-linked hyaluronic acid dermal filler designed for volumisation and contour support. It contains lidocaine hydrochloride to support patient comfort during injection. The product is classified as a medical-aesthetic injectable device and is intended for professional use only, in accordance with manufacturer guidance .
2: How does Aessoa Ultra differ from softer HA fillers?
Aessoa Ultra is positioned as a firmer HA gel compared with superficial or skin-booster-type fillers. Firmer gels are typically selected for areas requiring projection and structural support rather than fine line correction or hydration. Exact rheological properties are not disclosed by the manufacturer .
3: Does Aessoa Ultra contain lidocaine?
Yes. Aessoa Ultra contains lidocaine hydrochloride. The manufacturer does not publish the exact percentage in publicly available documentation. Lidocaine is included to help reduce discomfort during administration .
4: How long do results from Aessoa Ultra last?
The manufacturer does not provide an official longevity range. As with other cross-linked HA fillers, duration may vary based on anatomical area, injection depth, patient metabolism, and clinical technique. Practitioners should avoid assuming duration without IFU confirmation .
5: Is Aessoa Ultra suitable for lip augmentation?
Public distributor descriptions reference volumising applications; however, specific treatment indications, including lips, are not provided by manufacturer. Product selection for lip treatments should always be based on IFU guidance, anatomical knowledge, and practitioner training .
